FindTrial
Sign In

The effect of intravascular Lidocaine on Electrocardiogram in patients elected for Lower limb surgery under bupivacaiene spinal anesthesia

The effect of intravascular Lidocaine on QTc Interval in patients elected for Lower limb surgery under bupivacaiene spinal anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201008272832N1
Enrollment
50
Registered
2011-05-01
Start date
2010-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Limb Operation. Pre-excitation syndrome

Interventions

Intervention 1: Intravenous injection of Lidocaine 2% 1mg/kg as intervention, after spinal anesthesia with marcaine in the test group. Intervention 2: Intravenous Injection of saline 0.05 ml/kg as pl
Treatment - Drugs
Placebo
Intravenous injection of Lidocaine 2% 1mg/kg as intervention, after spinal anesthesia with marcaine in the test group.
Intravenous Injection of saline 0.05 ml/kg as placebo, after spinal anesthesia with marcaine in the Control group.

Sponsors

Deputy of Research Affairs, Shahrekord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ASA 2 patients elected for lower limb operation, Age more than 60 and less than 100 years, no contraindication for spinal anesthesia Exclusion criteria: Valvular heart diseases, History of treatment with cardiac medicine drugs, Conduction heart diseases and Abnormal ECG, Prolonged QTc interval more than 440 milliseconds

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
QTc interval. Timepoint: 1, 3, 5, 15, 30 minutes after Spinal Anesthesia. Method of measurement: 12 Leads Electrocardiography.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mahmood Akhlaghi

Shahrekord University of Medical Sciences

akhlaghi236@yahoo.com+98 38 1333 9629

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026